Mengying Huang, Ph.D.
Dr. Mengying Huang earned her B.Sc. in biotechnology, her M.Sc. in cell biology and her Ph.D. in biochemistry and molecular biology from Southwest University. While there, much of her research focused on elucidating the mechanisms underlying brain cancers, specifically glioblastoma and neuroblastoma. In 2018, she joined the lab of Dr. Xiaobing Shi at UT MD Anderson Cancer and, in April of that year, moved to Van Andel Institute along with the Shi Laboratory. Her primary research focus is to identify and characterize novel readers of histone modifications.